Protect Yourself While There’s Still Time …

The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.

4 simple steps to protect your privacy and money before it’s too late.

DAWN Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 8.40%

Insider Buying (Last 12 Months): $13,867,054.00

Insider Selling (Last 12 Months): $1,146,612.98

Day One Biopharmaceuticals Insider Trading History Chart

Day One Biopharmaceuticals Share Price & Price History

^$14.92

▲ +1.71 (12.94%)

As of 04/26/2024 01:00 AM ET

Days: 30 | 90 | 365

Better than Bitcoin? The Biotech Stock with 46,751% Potential

From Behind the Markets | Ad

4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.

Get the name of the stock here >>>

Day One Biopharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/18/2024	Samuel C. Blackman	Insider	Sell	10,000	$16.02	$160,200.00	1,174,662
3/25/2024	Samuel C. Blackman	Insider	Sell	10,000	$16.01	$160,100.00	1,184,662
2/27/2024	Samuel C. Blackman	Insider	Sell	20,000	$16.11	$322,200.00	1,224,662
2/16/2024	Adam Dubow	General Counsel	Sell	3,242	$15.25	$49,440.50	16,585
2/16/2024	Charles N York II	CFO	Sell	2,666	$15.25	$40,656.50	277,754
2/16/2024	Jeremy Bender	CEO	Sell	7,615	$15.25	$116,128.75	721,813
2/16/2024	Samuel C. Blackman	Insider	Sell	2,258	$15.25	$34,434.50	1,244,662
11/16/2023	Adam Dubow	General Counsel	Sell	5,313	$11.69	$62,108.97	11,428
11/16/2023	Charles N York II	CFO	Sell	956	$11.69	$11,175.64	270,170
11/16/2023	Jeremy Bender	CEO	Sell	3,107	$11.69	$36,320.83	709,429
11/16/2023	Samuel C. Blackman	Insider	Sell	709	$11.69	$8,288.21	1,238,234
10/19/2023	Ai Day1 Llc	Major Shareholder	Buy	384,400	$10.06	$3,867,064.00	12,817,935
8/17/2023	Charles N York II	CFO	Sell	922	$13.86	$12,778.92	267,501
8/17/2023	Jeremy Bender	CEO	Sell	2,996	$13.86	$41,524.56	704,224
8/17/2023	Samuel C. Blackman	Insider	Sell	668	$13.86	$9,258.48	1,236,319
6/9/2023	Ai Day1 Llc	Major Shareholder	Buy	769,230	$13.00	$9,999,990.00	11,453,868
6/5/2023	Samuel C. Blackman	Insider	Sell	1,229	$16.00	$19,664.00	1,234,363
5/16/2023	Charles N York II	CFO	Sell	955	$13.12	$12,529.60	264,798
5/16/2023	Jeremy Bender	CEO	Sell	3,104	$13.12	$40,724.48	1,179,484
5/16/2023	Samuel C. Blackman	Insider	Sell	692	$13.12	$9,079.04	1,235,592
3/10/2023	Samuel C. Blackman	Insider	Sell	10,000	$18.05	$180,500.00	1,233,660
3/7/2023	Jeremy Bender	CEO	Sell	12,500	$20.01	$250,125.00	1,174,276
2/16/2023	Charles N York II	CFO	Sell	930	$19.57	$18,200.10	271,505
2/16/2023	Jeremy Bender	CEO	Sell	3,022	$19.57	$59,140.54	1,186,776
2/16/2023	Samuel C. Blackman	Insider	Sell	674	$19.57	$13,190.18	1,243,660
2/10/2023	Samuel C. Blackman	Insider	Sell	10,000	$20.07	$200,700.00	1,241,710
1/23/2023	Jeremy Bender	CEO	Sell	12,500	$22.00	$275,000.00	1,181,486
1/20/2023	Charles N York II	CFO	Sell	10,000	$22.75	$227,500.00	268,810
1/10/2023	Samuel C. Blackman	Insider	Sell	10,000	$22.86	$228,600.00	1,250,148
1/3/2023	Julie Papanek Grant	Director	Sell	25,000	$20.65	$516,250.00	380,000
12/21/2022	Jeremy Bender	CEO	Sell	12,500	$20.32	$254,000.00	1,192,424
12/20/2022	Charles N York II	CFO	Sell	10,000	$20.07	$200,700.00	276,497
12/8/2022	Julie Papanek Grant	Director	Sell	4,358	$22.08	$96,224.64	405,000
12/1/2022	Julie Papanek Grant	Director	Sell	5,000	$21.75	$108,750.00	414,358
12/1/2022	Samuel C. Blackman	Insider	Sell	10,000	$21.45	$214,500.00	1,260,148
11/21/2022	Charles N York II	CFO	Sell	10,000	$20.76	$207,600.00	286,497
11/21/2022	Jeremy Bender	CEO	Sell	12,500	$20.76	$259,500.00	1,204,924
11/16/2022	Charles N York II	CFO	Sell	430	$21.46	$9,227.80	296,497
11/16/2022	Jeremy Bender	CEO	Sell	1,513	$21.46	$32,468.98	1,217,424
11/16/2022	Samuel C. Blackman	Insider	Sell	377	$21.46	$8,090.42	1,270,148
11/1/2022	Charles N York II	CFO	Sell	10,000	$20.03	$200,300.00	294,401
11/1/2022	Jeremy Bender	CEO	Sell	12,500	$20.03	$250,375.00	1,215,375
11/1/2022	Julie Papanek Grant	Director	Sell	5,000	$20.04	$100,200.00	424,358
10/3/2022	Charles N York II	CFO	Sell	10,000	$20.05	$200,500.00	304,401
10/3/2022	Jeremy Bender	CEO	Sell	12,500	$20.05	$250,625.00	1,227,875
10/3/2022	Julie Papanek Grant	Director	Sell	5,000	$20.06	$100,300.00	434,358
9/21/2022	Julie Papanek Grant	Director	Sell	613,603	$18.55	$11,382,335.65	8,464,301
9/20/2022	Xi L.P. Canaan	Major Shareholder	Sell	148,670	$19.51	$2,900,551.70	9,077,904
9/19/2022	Julie Papanek Grant	Director	Sell	76,725	$20.57	$1,578,233.25	9,226,574
9/16/2022	Xi L.P. Canaan	Major Shareholder	Sell	115,307	$21.55	$2,484,865.85	9,303,299
9/15/2022	Julie Papanek Grant	Director	Sell	51,281	$22.85	$1,171,770.85	9,418,606
9/14/2022	Xi L.P. Canaan	Major Shareholder	Sell	106,111	$23.68	$2,512,708.48	9,469,887
9/13/2022	Julie Papanek Grant	Director	Sell	87,647	$24.40	$2,138,586.80	9,575,998
9/2/2022	Papanek Julie Grant	Director	Sell	5,000	$23.82	$119,100.00	439,358
8/16/2022	Charles N York II	CFO	Sell	1,089	$24.31	$26,473.59	324,401
8/16/2022	Jeremy Bender	CEO	Sell	4,003	$24.31	$97,312.93	1,252,875
8/16/2022	Samuel C. Blackman	Insider	Sell	941	$24.31	$22,875.71	1,299,338
8/4/2022	Charles N York II	CFO	Sell	10,000	$20.05	$200,500.00	321,365
8/4/2022	Jeremy Bender	CEO	Sell	12,500	$20.00	$250,000.00	1,246,192
8/4/2022	Papanek Julie Grant	Director	Sell	5,000	$20.00	$100,000.00	454,358
8/1/2022	Samuel C. Blackman	Insider	Sell	10,000	$16.88	$168,800.00	1,296,718
7/18/2022	Charles N York II	CFO	Sell	2,500	$20.00	$50,000.00	331,365
7/18/2022	Papanek Julie Grant	Director	Sell	2,600	$20.00	$52,000.00	459,358
7/8/2022	Charles N York II	CFO	Sell	1,416	$20.00	$28,320.00	333,865
7/8/2022	Jeremy Bender	CEO	Sell	1,795	$20.00	$35,900.00	1,261,292
7/8/2022	Papanek Julie Grant	Director	Sell	1,242	$20.00	$24,840.00	461,958
7/5/2022	Charles N York II	CFO	Sell	800	$20.00	$16,000.00	335,281
7/5/2022	Jeremy Bender	CEO	Sell	857	$20.00	$17,140.00	1,263,087
7/1/2022	Charles N York II	CFO	Sell	1,479	$20.00	$29,580.00	336,081
7/1/2022	Jeremy Bender	CEO	Sell	1,746	$20.00	$34,920.00	1,263,944
7/1/2022	Papanek Julie Grant	Director	Sell	1,000	$20.00	$20,000.00	464,000
7/1/2022	Samuel C. Blackman	Insider	Sell	10,000	$18.72	$187,200.00	1,306,718
6/17/2022	Ai Day1 Llc	Major Shareholder	Buy	1,200,000	$15.00	$18,000,000.00	10,684,638
6/17/2022	Michael Gladstone	Director	Buy	766,667	$15.00	$11,500,005.00	766,667
6/15/2022	Samuel C. Blackman	Insider	Sell	50,000	$16.26	$813,000.00	1,316,718
1/20/2022	Ai Day1 Llc	Major Shareholder	Buy	4,615	$14.73	$67,978.95
1/18/2022	Ai Day1 Llc	Major Shareholder	Buy	43,429	$14.26	$619,297.54
1/3/2022	Samuel C. Blackman	Insider	Sell	10,000	$17.10	$171,000.00
12/8/2021	Pharmaceutical Co Ltd Takeda	Major Shareholder	Sell	110,338	$18.03	$1,989,394.14
12/6/2021	Pharmaceutical Co Ltd Takeda	Major Shareholder	Sell	97,692	$18.05	$1,763,340.60
12/3/2021	Pharmaceutical Co Ltd Takeda	Major Shareholder	Sell	12,517	$18.47	$231,188.99
12/1/2021	Samuel C. Blackman	Insider	Sell	10,000	$17.22	$172,200.00

Better than Bitcoin? The Biotech Stock with 46,751% Potential

From Behind the Markets | Ad

4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.

Get the name of the stock here >>>

SEC Filings (Institutional Ownership Changes) for Day One Biopharmaceuticals (NASDAQ:DAWN)

87.95% of Day One Biopharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Day One Biopharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/17/2024	Hennion & Walsh Asset Management Inc.	59,289	$0.98M	0.1%	+2.5%	0.068%
3/5/2024	Fisher Asset Management LLC	68,446	$1M	0.0%	+89.0%	0.078%
3/5/2024	Wellington Management Group LLP	208,969	$3.05M	0.0%	+77.7%	0.239%
3/1/2024	Goldman Sachs Group Inc.	2,118,849	$30.94M	0.0%	+28.7%	2.425%
2/29/2024	Quintet Private Bank Europe S.A.	3,313	$48K	0.0%	+43.2%	0.004%
2/20/2024	Quarry LP	5,000	$73K	0.0%	-23.3%	0.006%
2/15/2024	PFM Health Sciences LP	1,303,575	$19.03M	1.1%	-41.4%	1.498%
2/15/2024	Parkman Healthcare Partners LLC	625,749	$9.14M	1.3%	+34.2%	0.719%
2/14/2024	Braidwell LP	4,215,573	$61.55M	2.3%	+13.5%	4.843%
2/14/2024	Superstring Capital Management LP	379,626	$5.54M	4.0%	N/A	0.436%
2/13/2024	Rafferty Asset Management LLC	236,347	$3.45M	0.0%	-0.3%	0.272%
2/13/2024	NEOS Investment Management LLC	15,507	$0.23M	0.0%	N/A	0.018%
2/9/2024	Franklin Resources Inc.	4,236,795	$61.86M	0.0%	+4.2%	4.868%
2/9/2024	Quest Partners LLC	1,980	$29K	0.0%	N/A	0.002%
2/9/2024	Dynamic Technology Lab Private Ltd	10,651	$0.16M	0.0%	N/A	0.012%
2/8/2024	Nicholas Investment Partners LP	303,318	$4.43M	0.5%	-86.1%	0.348%
2/8/2024	First Turn Management LLC	1,700,949	$24.83M	3.6%	N/A	1.954%
2/7/2024	Teacher Retirement System of Texas	10,860	$0.16M	0.0%	-15.7%	0.012%
2/7/2024	TimesSquare Capital Management LLC	1,666,065	$24.33M	0.4%	+45.8%	1.914%
2/6/2024	Charles Schwab Investment Management Inc.	452,934	$6.61M	0.0%	+1.3%	0.520%
2/6/2024	Fisher Asset Management LLC	68,411	$1M	0.0%	+88.9%	0.079%
2/1/2024	New York State Common Retirement Fund	78,299	$1.14M	0.0%	+20.5%	0.090%
2/1/2024	Handelsbanken Fonder AB	17,400	$0.25M	0.0%	N/A	0.020%
1/30/2024	Zurcher Kantonalbank Zurich Cantonalbank	6,978	$0.10M	0.0%	-24.6%	0.008%
1/30/2024	Vontobel Holding Ltd.	15,500	$0.23M	0.0%	-34.9%	0.018%
1/24/2024	Arizona State Retirement System	13,373	$0.20M	0.0%	+8.2%	0.015%
1/24/2024	China Universal Asset Management Co. Ltd.	10,067	$0.15M	0.0%	+352.2%	0.012%
1/16/2024	Legato Capital Management LLC	41,918	$0.61M	0.1%	+14.3%	0.048%
1/12/2024	SG Americas Securities LLC	64,692	$0.95M	0.0%	+74.9%	0.074%
1/5/2024	Exchange Traded Concepts LLC	10,072	$0.15M	0.0%	+34.0%	0.012%
12/18/2023	Vanguard Group Inc.	4,629,754	$56.81M	0.0%	+8.1%	5.319%
12/1/2023	Wellington Management Group LLP	117,576	$1.44M	0.0%	+5.0%	0.135%
11/22/2023	Polar Capital Holdings Plc	1,935,000	$23.74M	0.2%	+9.0%	2.223%
11/21/2023	Walleye Capital LLC	277,206	$3.40M	0.0%	N/A	0.318%
11/17/2023	TimesSquare Capital Management LLC	1,142,610	$14.02M	0.2%	+41.8%	1.313%
11/15/2023	Adage Capital Partners GP L.L.C.	1,036,599	$12.72M	0.0%	-57.6%	1.191%
11/15/2023	Alps Advisors Inc.	64,153	$0.79M	0.0%	+2.5%	0.074%
11/14/2023	Braidwell LP	3,715,573	$45.59M	1.4%	+10.5%	4.269%
11/14/2023	Schonfeld Strategic Advisors LLC	136,700	$1.68M	0.0%	+18.3%	0.157%
11/14/2023	Trexquant Investment LP	97,868	$1.20M	0.0%	N/A	0.112%
11/14/2023	Profund Advisors LLC	40,245	$0.49M	0.0%	-23.5%	0.046%
11/13/2023	Algert Global LLC	33,062	$0.41M	0.0%	-32.5%	0.038%
11/13/2023	FMR LLC	6,026,128	$73.94M	0.0%	-20.3%	6.923%
11/13/2023	Rafferty Asset Management LLC	237,084	$2.91M	0.0%	-18.5%	0.272%
11/13/2023	E Fund Management Co. Ltd.	12,176	$0.15M	0.0%	-22.2%	0.014%
11/9/2023	Deutsche Bank AG	177,137	$2.17M	0.0%	+5.5%	0.204%
11/9/2023	Citigroup Inc.	100,665	$1.24M	0.0%	+4.4%	0.116%
11/8/2023	State Board of Administration of Florida Retirement System	17,880	$0.22M	0.0%	+27.9%	0.021%
11/8/2023	Charles Schwab Investment Management Inc.	447,138	$5.49M	0.0%	+38.8%	0.514%
11/8/2023	Swiss National Bank	95,400	$1.17M	0.0%	-14.3%	0.110%
11/8/2023	Amalgamated Bank	8,628	$0.11M	0.0%	+35.7%	0.010%
11/7/2023	New York State Common Retirement Fund	65,005	$0.80M	0.0%	-11.0%	0.075%
11/7/2023	Barclays PLC	131,882	$1.62M	0.0%	-8.7%	0.152%
11/7/2023	Arizona State Retirement System	12,363	$0.15M	0.0%	+8.8%	0.014%
11/2/2023	Principal Financial Group Inc.	17,781	$0.22M	0.0%	+9.7%	0.020%
10/31/2023	Teacher Retirement System of Texas	12,883	$0.16M	0.0%	-6.8%	0.015%
10/31/2023	China Universal Asset Management Co. Ltd.	2,226	$27K	0.0%	+130.9%	0.003%
10/27/2023	Hennion & Walsh Asset Management Inc.	53,803	$0.66M	0.0%	+89.5%	0.062%
10/27/2023	TD Asset Management Inc	55,196	$0.68M	0.0%	+100.0%	0.063%
10/26/2023	Mirae Asset Global Investments Co. Ltd.	43,567	$0.54M	0.0%	+24.3%	0.050%
10/24/2023	Bank of New York Mellon Corp	220,296	$2.70M	0.0%	+22.4%	0.253%
10/18/2023	Exchange Traded Concepts LLC	7,518	$92K	0.0%	-27.8%	0.009%
10/13/2023	SG Americas Securities LLC	36,980	$0.45M	0.0%	+58.7%	0.043%
10/12/2023	Legato Capital Management LLC	36,676	$0.45M	0.1%	-16.1%	0.042%
10/11/2023	Canaan Partners XI LLC	2,491,561	$30.57M	26.8%	-2.2%	2.865%
9/12/2023	Davidson Kempner Capital Management LP	40,000	$0.48M	0.0%	N/A	0.046%
8/15/2023	RA Capital Management L.P.	7,809,852	$93.25M	1.8%	+10.9%	8.980%
8/15/2023	Sphera Funds Management LTD.	530,000	$6.33M	1.0%	N/A	0.609%
8/15/2023	Braidwell LP	3,361,813	$40.14M	1.3%	+6.4%	3.865%
8/14/2023	UniSuper Management Pty Ltd	175,000	$2.09M	0.0%	N/A	0.201%
8/14/2023	Driehaus Capital Management LLC	478,106	$5.71M	0.1%	+1.3%	0.550%
8/14/2023	Polar Capital Holdings Plc	1,774,615	$21.19M	0.1%	+26.8%	2.040%
8/14/2023	Prelude Capital Management LLC	11,900	$0.14M	0.0%	N/A	0.014%
8/11/2023	Franklin Resources Inc.	4,065,668	$48.54M	0.0%	+19.3%	4.675%
8/11/2023	Artal Group S.A.	500,000	$5.97M	0.2%	N/A	0.575%
8/11/2023	E Fund Management Co. Ltd.	15,641	$0.19M	0.0%	+43.9%	0.018%
8/11/2023	ExodusPoint Capital Management LP	187,185	$2.24M	0.0%	N/A	0.254%
8/10/2023	Monashee Investment Management LLC	199,900	$2.39M	0.6%	N/A	0.272%
8/10/2023	Metropolitan Life Insurance Co NY	2,736	$33K	0.0%	+77.2%	0.004%
8/10/2023	Profund Advisors LLC	52,632	$0.63M	0.0%	+49.0%	0.072%
8/10/2023	Nicholas Investment Partners LP	2,237,111	$26.71M	1.8%	+39.5%	3.041%
8/10/2023	Citigroup Inc.	96,431	$1.15M	0.0%	-37.0%	0.131%
8/9/2023	TimesSquare Capital Management LLC	805,700	$9.62M	0.1%	N/A	1.095%
8/8/2023	AlphaCentric Advisors LLC	110,000	$1.31M	0.7%	N/A	0.150%
8/8/2023	Candriam S.C.A.	290,014	$3.46M	0.0%	+52.5%	0.394%
8/7/2023	Principal Financial Group Inc.	16,212	$0.19M	0.0%	+18.2%	0.022%
8/4/2023	American International Group Inc.	23,697	$0.28M	0.0%	+77.3%	0.032%
8/3/2023	Bank of New York Mellon Corp	179,909	$2.15M	0.0%	+61.2%	0.245%
8/2/2023	Bank of Montreal Can	37,895	$0.51M	0.0%	N/A	0.052%
8/1/2023	Regency Capital Management Inc. DE	12,000	$0.14M	0.1%	N/A	0.016%
8/1/2023	Arizona State Retirement System	11,368	$0.14M	0.0%	N/A	0.015%
7/24/2023	Vontobel Holding Ltd.	23,800	$0.28M	0.0%	N/A	0.032%
7/20/2023	Exchange Traded Concepts LLC	10,413	$0.12M	0.0%	N/A	0.014%
7/19/2023	Teacher Retirement System of Texas	13,825	$0.17M	0.0%	N/A	0.019%
7/10/2023	SG Americas Securities LLC	23,297	$0.28M	0.0%	+35.8%	0.032%
5/25/2023	Legato Capital Management LLC	29,992	$0.40M	0.1%	+26.2%	0.041%
5/16/2023	Great Point Partners LLC	141,526	$1.89M	0.4%	-74.0%	0.192%
5/16/2023	Atlas Venture Life Science Advisors LLC	7,608,394	$101.72M	13.8%	+0.5%	10.341%
5/12/2023	Quintet Private Bank Europe S.A.	2,315	$31K	0.0%	N/A	0.003%
5/12/2023	Nicholas Investment Partners LP	1,603,390	$21.44M	1.6%	+103.8%	2.179%

Data available starting January 2016

Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genomically defined cancers. Its lead product candidate is tovorafenib, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/ refractory low-grade glioma. The company is also developing Pimasertib, an oral small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Brisbane, California.

Today's Range

Now: $14.92

$13.23

$15.10

50 Day Range

MA: $15.22

$13.21

$17.46

52 Week Range

Now: $14.92

$9.67

$17.85

Volume

3,603,133 shs

Average Volume

844,853 shs

Market Capitalization

$1.30 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Day One Biopharmaceuticals?: Day One Biopharmaceuticals' top insider investors include:
Ai Day1 Llc (Major Shareholder)
Julie Papanek Grant (Director)
Xi LP Canaan (Major Shareholder)
Samuel C Blackman (Insider)
Jeremy Bender (CEO)
Michael Gladstone (Director)
Papanek Julie Grant (Director)
Charles N York II (CFO)
Adam Dubow (General Counsel)
Learn More about top insider investors at Day One Biopharmaceuticals.
Who are the major institutional investors of Day One Biopharmaceuticals?: Day One Biopharmaceuticals' top institutional shareholders include:
Hennion & Walsh Asset Management Inc. — 0.07%
Learn More about top institutional investors of Day One Biopharmaceuticals stock.
Which major investors are buying Day One Biopharmaceuticals stock?: Within the previous quarter, DAWN stock was bought by institutional investors including:
Hennion & Walsh Asset Management Inc.
Within the last year, these company insiders have bought Day One Biopharmaceuticals stock:
Ai Day1 Llc (Major Shareholder)
Julie Papanek Grant (Director)
Learn More investors buying Day One Biopharmaceuticals stock.